1.Van Boeckel, TP et al. (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet Infectious Diseases 14, 742–750.
2.Klein, EY et al. (2018) Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences of the USA 115, E3463–E3470.
3.Albrich, WC, Monnet, DL and Harbarth, S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerging Infectious Diseases 10, 514–517.
4.Davies, J and Davies, D (2010) Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews 74, 417–433.
5.Zilberberg, MD et al. (2017) Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infectious Diseases 17, 279.
6.Tello, A, Austin, B and Telfer, TC (2012) Selective pressure of antibiotic pollution. Environmental Health Perspectives 120, 1100–1106.
7.Folgori, L et al. (2014) Epidemiology and clinical outcomes of multidrug-resistant, Gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period. The Pediatric Infectious Disease Journal 33, 929–932.
8.Friedman, ND, Temkin, E and Carmeli, Y (2016) The negative impact of antibiotic resistance. Clinical Microbiology and Infection 22, 416–422.
9.Tsai, M-H et al. (2014) Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics 133, e322–e329.
10.WHO (2014) Antimicrobial Resistance: Global Report on Surveillance. Geneva, Switzerland: World Health Organization.
11.European Centre for Disease Prevention and Control (2017) Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC.
12.CDC (2013) Antibiotic Resistance Threats in the United States, 2013. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 49–92.
13.ECDC/EMEA (2009) The Bacterial Challenge: Time to React. A Call to Narrow the Gap Between Multidrug-Resistant bacteria in the EU and the Development of new Antibacterial Agents. Stockholm, Sweden: ECDC.
14.O'Neil, J (2014) Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. London, England: The Review on Antimicrobial Resistance Chaired by Jim O'Neill.
15.Colomb-Cotinat, M et al. (2016) Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012. Antimicrobial Resistance & Infection Control 5, 56.
16.Cassini, A et al. (2018) Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet ID 19, 56–66.
17.Guy, R et al. (2016) Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales. Journal of Antimicrobial Chemotherapy 71, 1564–1569.
18.Temkin, E et al. (2018) Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. The Lancet Global Health 6, e969–e979.
19.de Kraker, MEA, Stewardson, AJ and Harbarth, S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Medecine 13, e1002184.
20.WHO (2015) International Statistical Classification of Diseases and Related Health Problems, 2nd Edn. 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization.
21.Tuppin, P et al. (2017) Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Revue d'Epidemiologie et de Santé Publique 65, S149–S167.
22.Charlson, ME et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40, 373–383.
26.Arnaud, L et al. (2014) Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study. Autoimmunity Reviews 13, 1082–1089.
27.Poujois, A et al. (2017) Characteristics and prevalence of Wilson's disease: a 2013 observational population-based study in France. Clinics and Research in Hepatology and Gastroenterology 42, 57–63.
28.Foulon, S et al. (2017) Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data. Journal of Neurology 264, 1185–1192.
29.Grammatico-Guillon, L et al. (2014) Quality assessment of hospital discharge database for routine surveillance of hip and knee arthroplasty-related infections. Infection Control and Hospital Epidemiology 35, 646–651.
30.Prat, M et al. (2017) Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database. Fundamental & Clinical Pharmacology 32, 108–113.
31.Sahli, L et al. (2016) Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database. Pharmacoepidemiology and Drug Safety 25, 785–789.
32.Girard, D, Antoine, D and Che, D (2014) Epidemiology of pulmonary tuberculosis in France. Can the hospital discharge database be a reliable source of information? Médecine et Maladies Infectieuses 44, 509–514.
33.Afshar, P et al. (2013) Prevalence of resistance to antibiotics according to international classification of diseases (ICD-10) in Boo Ali Sina Hospital of Sari, 2011–2012. Medical Archives 67, 329–432.
34.Arnaud, I and Jarlier, V (2017) Surveillance des bactéries multirésistantes dans les établissements de santé en France. Réseau BMR-Raisin : résultats 2016. [Surveillance of multi-resistant bacteria in health care facilities in France. BMR-Raisin network: results 2016]. Saint-Maurice: Santé publique France. 106p.